Product
Lidocaine patch
2 clinical trials
3 indications
Indication
HealthyIndication
Liver CancerIndication
Post-Ablation SyndromeClinical trial
Phase 1, Randomized, Comparative Pharmacokinetic Study of Bolus Intravenous Lidocaine 0.7 mg/kg, Lidocaine Patch 1.8%, and Lidocaine Patch 5% (Lidoderm®) in Healthy SubjectsStatus: Completed, Estimated PCD: 2014-07-24
Clinical trial
The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation: A Randomized, Double-blind, Placebo-controlled StudyStatus: Completed, Estimated PCD: 2018-04-30